Frost & Sullivan Acknowledges Euro Diagnostica AB's Excellence In Product Differentiation
LONDON, April 30, 2013 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics market, Frost & Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award.
"Euro Diagnostica offers a range of high-quality enzyme linked immunosorbent assay (ELISA) kits for autoimmune diagnostics," noted Frost & Sullivan Senior Research Analyst Srinivas Sashidhar. "Together with world class scientists Euro Diagnostica has been the first to develop and produce the gold standard testing for autoantibodies to citrullinated proteins/peptide (anti-CCP autoantibodies) for rheumatoid arthritis through its anti-CCP2 ELISA kit Immunoscan CCPlus ®."
In addition, Euro Diagnostica has been the first to develop anti-neutrophil cytoplasmic antibodies (ANCA) tests for diagnosing systemic vasculitis and related diseases. Wieslab ® Capture ANCA ELISA is based on the capture technique developed by Euro Diagnostica to better optimise antigen presentation.
"Clinical evaluation of capture assays for determining PR3 ANCA shows that this format has a higher diagnostic sensitivity for detecting patients with potentially life threatening granulomatosis with polyangiitis (GPA), compared with the direct coating method or indirect immunofluorescence," remarked Sashidhar.Another unique product line is the Euro Diagnostica complement test system, Wieslab ® Complement ELISA that consists of functional assessments of all three pathways - classical, alternative and lectin - in a simple and accurate ELISA format. Assessment of the three pathways can be carried out with separate ELISA kits or in a combined kit. Euro Diagnostica, as a partner of Dynex, has harmonised all ELISA tests to the DSX and DS2 platform. Earlier this year, the company also added EULISA tests to its existing product line for autoimmune diagnostics. "All the diagnostic products developed by Euro Diagnostica are compatible and customised for clinical autoimmunology, microbiology, and immunochemistry laboratories," stated Sashidhar. "The Dynex instrument is an open and flexible diagnostic solution, which can be tailored for a range of autoimmune diseases, including localised and systemic diseases.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts